RFP for Opioid Use Disorder Treatment Medications

The state of Texas, through Integral Care, a community-based behavioral health and intellectual/developmental disabilities services provider in Travis County, is seeking proposals for the sale of opioid use disorder treatment medications, including methadone, buprenorphine, and buprenorphine/naloxone. The Request for Proposal (RFP) covers the jurisdictions of Travis County and the City of Austin, Texas. Integral Care is soliciting proposals from qualified and DEA-licensed proposers to provide these medications for use in its Narcotic Treatment Program, which serves between 450-500 patients annually. The RFP outlines the specific products and quantities required, as well as the scoring criteria, which includes responses to the proposal instructions, ability to meet specifications, purchasing procedures, implementation timeline, cost, and whether the proposer is HUB-certified or HUB-qualified. The deadline to submit proposals is 5:00 p.m. CDT on December 19, 2023, and Integral Care anticipates awarding one or more contracts for the products commencing on approximately February 1, 2024.

Historically Underutilized Businesses, including Minority-Owned Businesses and Women-Owned Businesses, are encouraged to apply for this opportunity. The RFP does not provide any information about incumbent vendors or current contractors, nor does it specify any award values or budget ranges. However, the RFP does outline the successful proposer(s) will be required to maintain various insurance coverages, comply with all applicable federal, state, county and local laws, regulations, codes, standards, and Integral Care policies and procedures, and be subject to performance standards and the ability for Integral Care to terminate the contract without penalty for any reason.